
Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma
Niels W.C.J. Van De Donk, Shulamit Wittebol, Monique C. Minnema, Henk M. LokhorstVolume:
148
Année:
2010
Langue:
english
Pages:
3
DOI:
10.1111/j.1365-2141.2009.07931.x
Fichier:
PDF, 65 KB
english, 2010